Please login to the form below
BPR Pharma strengthens research team
Vicky Davies joins the UK-based international research agency from Bedrock Healthcare
UK-based international research agency BPR Pharma has appointed Vicky Davies as its new research director following 15 years partnering with pharmaceutical, medical device and consumer health clients.
Most recently, Davies headed up the insight department for Bedrock Communications as its research director.
She said: “I’m very excited to be joining Matt and Bridget on their quest to offer a more human approach to healthcare market research.
“BPR has a genuine interest and ability to understand people and their behaviour and their engaging, no nonsense deliverables give clients the means to move forward.”
Prior to her new role, Davies has worked in several senior research roles for agencies including Spinach and Morpace, as well as in-house for global devices manufacturer Coviden - now Medtronic.
BPR said: “Vicky is a hugely enthusiastic, creative researcher with a wealth of client-and agency-side experience.
“She shares our commitment to research excellence and understands the importance of engaging audiences in all aspects of the work we do.”
Subscribe to our email news alerts
- Sanofi and Teva to collaborate on inflammatory bowel disease drug in deal worth $1.5bn
- Eli Lilly to acquire cancer specialist Point Biopharma in deal worth $1.4bn
- Regeneron and Intellia to develop additional gene editing therapies under expanded collaboration
- Novavax’s updated COVID-19 vaccine approved by FDA for emergency use
- Alzheimer’s Research UK awards Cardiff University researchers £387,000
- Actinic keratosis – a common skin condition that can lead to skin cancer
No results were found
PMHub
IPG Health Medical Communications
We are the world's most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity...
Latest intelligence
- Actinic keratosis – a common skin condition that can lead to skin cancer
- PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
